Emmaus Life Sciences Announces Collaboration with Kier (Junior) Spates to Share Personal Experience with Sickle Cell Disease and Endari® PR Newswire TORRANCE, Calif., Sept. 28, 2022 Nationally Syndicated Radio Programming Will Educate and Support SCD Patients TORRANCE, Calif. , Sept. 28, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA) a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced a collaboration with the Steve...